In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
In the latest session, ARS Pharmaceuticals Inc (NASDAQ: SPRY) closed at $13.32 down -8.20% from its previous closing price of $14.51. In other words, the price has decreased by -$8.20 from its previous closing price. On the day, 1.19 million shares were traded. SPRY stock price reached its highest trading level at $14.395 during the session, while it also had its lowest trading level at $13.26.
Ratios:
For a deeper understanding of ARS Pharmaceuticals Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 12.50 and its Current Ratio is at 12.54. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
On August 13, 2024, Raymond James Upgraded its rating to Strong Buy which previously was Outperform and also upped its target price recommendation from $18 to $22.
Leerink Partners reiterated its Outperform rating for the stock on August 12, 2024, while the target price for the stock was revised from $19 to $20.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Dec 02 ’24 when Chakma Justin bought 45,000 shares for $14.51 per share.
Shawver Laura bought 200,000 shares of SPRY for $2,713,000 on Dec 02 ’24. On Dec 02 ’24, another insider, ERIC KARAS, who serves as the Officer of the company, bought 3,717 shares for $14.11 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SPRY now has a Market Capitalization of 1294510848 and an Enterprise Value of 1087948672. For the stock, the TTM Price-to-Sale (P/S) ratio is 503.01 while its Price-to-Book (P/B) ratio in mrq is 6.44. Its current Enterprise Value per Revenue stands at 423.656 whereas that against EBITDA is -17.999.
Stock Price History:
Over the past 52 weeks, SPRY has reached a high of $18.51, while it has fallen to a 52-week low of $4.76. The 50-Day Moving Average of the stock is -9.95%, while the 200-Day Moving Average is calculated to be 19.58%.
Shares Statistics:
For the past three months, SPRY has traded an average of 1.05M shares per day and 969640 over the past ten days. A total of 97.15M shares are outstanding, with a floating share count of 50.84M. Insiders hold about 47.79% of the company’s shares, while institutions hold 42.07% stake in the company. Shares short for SPRY as of 1731628800 were 13852113 with a Short Ratio of 13.14, compared to 1728950400 on 11915667. Therefore, it implies a Short% of Shares Outstanding of 13852113 and a Short% of Float of 26.8.
